|
[1]CZAJA AJ.Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis[J].Dig Dis Sci, 2017, 62 (9) :2277-2292.
|
|
[2]CHRISTEN U, HINTERMANN E.Pathogens and autoimmune hepatitis[J].Clin Exp Immunol, 2019, 195 (1) :35-51.
|
|
[3]MIELI-VERGANI G, VERGANI D, CZAJA AJ, et al.Autoimmune hepatitis[J].Nat Rev Dis Primers, 2018, 4:18017.
|
|
[4]SCHMELTZER PA, RUSSO MW.Clinical narrative:Autoimmune hepatitis[J].Am J Gastroenterol, 2018, 113 (7) :951-958.
|
|
[5]European Association for the Study of the Liver.EASL clinical practice guidelines:Autoimmune hepatitis[J].J Hepatology, 2015, 63 (4) :971-1004.
|
|
[6]CZAJA AJ.Diagnosis and management of autoimmune hepatitis:Current status and future directions[J].Gut Liver, 2016, 10 (2) :177-203.
|
|
[7]CZAJA AJ.Diagnosis and management of autoimmune hepatitis[J].Clin Liver Dis, 2015, 19 (1) :57-79.
|
|
[8]LIBERAL R, KRAWITT EL, VIERLING JM, et al.Cutting edge issues in autoimmune hepatitis[J].J Autoimmune, 2016, 75:6-19.
|
|
[9]FLOREANI A, LIBERAL R, VERGANI D, et al.Autoimmune hepatitis:Contrasts and comparisons in children and adults-a comprehensive review[J].J Autoimmune, 2013, 46:7-16.
|
|
[10]LIWINSKI T, SCHRAMM C.Autoimmune hepatitis-update on clinical management in 2017[J].Clin Res Hepatology Gastroenterol, 2017, 41 (6) :617-625.
|
|
[11]SEBODE M, WELLLER-NORMANN C, LIWINSKI T, et al.Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance[J].Front Immunol, 2018, 9:609.
|
|
[12]MANNS MP, LOHSE AW, VERGANI D.Autoimmune hepatitis-update 2015[J].J Hepatology, 2015, 62 (1 Suppl) :s100-s111.
|
|
[13]JIMNEZ-RIVERA C, LING SC, AHMED N, et al.Incidence and characteristics of autoimmune hepatitis[J].Pediatrics, 2015, 136 (5) :e1237-e1248.
|
|
[14]ZACHOU K, MURATORI P, KOUKOULIS GK, et al.Review article:Autoimmune hepatitis-current management and challenges[J].Aliment Pharmacol Ther, 2013, 38 (8) :887-913.
|
|
[15]GATSELIS NK, ZACHOU K, KOUKOULIS GK, et al.Autoimmune hepatitis, one disease with many faces:Etiopathogenetic, clinico-laboratory and histological characteristics[J].World J Gastroenterol, 2015, 21 (1) :60-83.
|
|
[16]CHRISTEN U, HINTERMANN E.Autoantibodies in autoimmune hepatitis:Can epitopes tell us about the etiology of the disease?[J].Front Immunol, 2018, 9:163.
|
|
[17]MACKAY IR.Autoimmune hepatitis:From the clinic to the diagnostics laboratory[J].Lab Med, 2011, 42 (4) :224-233.
|
|
[18]SAHEBJAM F, VIERLING JM.Autoimmune hepatitis[J].Front Med, 2015, 9 (2) :187-219.
|
|
[19]TERZIROLI BERETTA-PICCOLI B, MIELI-VERGANI G, VERGA-NI D.Serology in autoimmune hepatitis:A clinical-practice approach[J].Eur J Intern Med, 2018, 48:35-43.
|
|
[20]TERZIROLI BERETTA-PICCOLI B, MIELI-VERGANI G, VERGA-NI D.The clinical usage and definition of autoantibodies in immune-mediated liver disease:A comprehensive overview[J].JAutoimmune, 2018, 95:144-158.
|
|
[21]SHEN L, SURESH L.Autoantibodies, detection methods and panels for diagnosis of Sj9gren's syndrome[J].Clin Immunol, 2017, 182:24-29.
|
|
[22]LIBERAL R, MIELI-VERGANI G, VERGANI D.Clinical significance of autoantibodies in autoimmune hepatitis[J].J Autoimmune, 2013, 46:17-24.
|
|
[23]SAWALHA AH, HARLEY JB.Antinuclear autoantibodies in systemic lupus erythematosus[J].Curr Opin Rheumatol, 2004, 16 (5) :534-540.
|
|
[24]di SABATINO A, BIAGI F, LENZI M, et al.Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases[J].Dig Liver Dis, 2017, 49 (9) :947-956.
|
|
[25]WANG Q, YANG F, MIAO Q, et al.The clinical phenotypes of autoimmune hepatitis:A comprehensive review[J].J Autoimmune, 2016, 66:98-107.
|
|
[26]BERG P, STECHEMESSER E, STRIENZ J.Hypergammaglobulinmische chronisch aktive Hepatitis mit Nachweis von leber-pankreasspezifischen komplementbindenden Autoantik9rpern[J].Verh Dtsch Ges Inn Med, 1981, 87:921-927.
|
|
[27]MANNS M, GERKEN G, KYRIATSOULIS A, et al.Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen[J].Lancet, 1987, 1 (8528) :292-294.
|
|
[28]WIES I, BRUNNER S, HENNINGER J, et al.Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis[J].Lancet, 2000, 355 (9214) :1510-1515.
|
|
[29]MURATORI P, LENZI M, CASSANI F, et al.Diagnostic approach to autoimmune hepatitis[J].Expert Rev Clin Immunol, 2017, 13 (8) :769-779.
|
|
[30]TOH BH.Diagnostic autoantibodies for autoimmune liver diseases[J].Clin Transl Immunology, 2017, 6 (5) :e139.
|
|
[31]VERGANI D, ALVAREZ F, BIANCHI FB, et al.Liver autoimmune serology:A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group[J].J Hepatology, 2004, 41 (4) :677-683.
|
|
[32]BRAHIM I, BRAHIM I, HAZIME R, et al.Autoimmune hepatitis:Immunological diagnosis[J].Presse Med, 2017, 46 (11) :1008-1019.
|
|
[33]WANG QX, YAN L, MA X.Autoimmune hepatitis in the AsiaPacific area[J].J Clin Transl Hepatology, 2018, 6 (1) :48-56.
|
|
[34]RIZZETTO M, SWANA G, DONIACH D.Microsomal antibodies in active chronic hepatitis and other disorders[J].Clin Exp Immunol, 1973, 15 (3) :331-344.
|
|
[35]HOMBERG JC, ABUAF N, BERNARD O, et al.Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1:A second type of"autoimmune"hepatitis[J].Hepatology, 1987, 7 (6) :1333-1339.
|
|
[36]AIZAWA Y, HOKSRI A.Autoimmune hepatitis:Current challenges and future prospects[J].Clin Exp Gastroenterol, 2017, 10:9-18.
|
|
[37]MITRA S, MINZ RW.Autoantibodies in autoimmune liver diseases-methods of detection and interpretation:An update for the reporting pathologist[J].Int J Surg Pathol, 2016, 24 (7) :576-585.
|
|
[38]MARTINI E, ABUAF N, CAVALLI F, et al.Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2[J].Hepatology, 1988, 8 (6) :1662-1666.
|
|
[39]ASHWELL G, MORELL AG.The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins[J].Adv Enzymol Relat Areas Mol Biol, 1974, 41 (0) :99-128.
|
|
[40]BELAND K, LAPIERRE P, MARCEAU G, et al.Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection[J].J Autoimmune, 2004, 22 (2) :159-166.
|
|
[41]LOHSE AW, GERKEN G, MOHR H, et al.Relation between autoimmune liver diseases and viral hepatitis:Clinical and serological characteristics in 859 patients[J].Z Gastroenterol, 1995, 33 (9) :527-533.
|
|
[42]MURATORI P, EFE C, MURATORI L, et al.Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis:A multicenter study[J].Eur J Gastroenterol Hepatology, 2017, 29 (7) :777-780.
|
|
[43]MURATORI P, LENZI M, MIGLIORI M, et al.Antimitochondrial antibodies positive autoimmune hepatitis with acute onset[J].Scandinavian J Gastroenterol, 2017, 52 (8) :920-921.
|
|
[44]CZAJA AJ, MORSHED SA, PARVEEN S, et al.Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis[J].Hepatology, 1997, 26 (3) :567-572.
|
|
[45]NGUYEN HH, SHAHEEN AA, BAEZA N, et al.Evaluation of classical and novel autoantibodies for the diagnosis of primary biliary cholangitis-autoimmune hepatitis overlap Syndrome (PBC-AIH OS) [J].PLo S One, 2018, 13 (3) :e0193960.
|
|
[46]MURATORI P, GRANITO A, PAPPAS G, et al.The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome[J].Am J Gastroenterol, 2009, 104 (6) :1420-1425.
|
DownLoad: